Repurposing of FDA Approved Drugs and Neuropep peptides as Anticancer Agents Against ErbB1 and ErbB2 - Patnaik, S K; Swaroop, A K; Naik, M R; Selvaraj, J; Chandrasekar, MJ N (Drug Res (Stuttg), 2023)